{
  "paper_metadata": {
    "pmid": "31780705",
    "title": "Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data from the study."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9127delG",
      "protein_notation": "p.E3043fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Age not specified, HGSC subtype",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "HGSC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation",
      "source_location": "Table 2, Row 5",
      "additional_notes": "This variant was identified in a patient with HGSC.",
      "key_quotes": [
        "BRCA2 mutation was identified in one patient each of CCC, EC, and MC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.845_846insTTTGG",
      "protein_notation": "p.H282fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Age not specified, HGSC subtype",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "HGSC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation",
      "source_location": "Table 2, Row 6",
      "additional_notes": "This variant was identified in a patient with HGSC.",
      "key_quotes": [
        "BRCA2 mutation was identified in one patient each of CCC, EC, and MC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.C9076T",
      "protein_notation": "p.Q3026X",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "Age not specified, one in HGSC and one in CCC subtype",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "HGSC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "CCC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation",
      "source_location": "Table 2, Row 7",
      "additional_notes": "This variant was identified in patients with HGSC and CCC.",
      "key_quotes": [
        "BRCA2 mutation was identified in one patient each of CCC, EC, and MC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5718_5719del",
      "protein_notation": "p.N1906fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Age not specified, EC subtype",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "EC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation",
      "source_location": "Table 2, Row 8",
      "additional_notes": "This variant was identified in a patient with EC.",
      "key_quotes": [
        "BRCA2 mutation was identified in one patient each of CCC, EC, and MC."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.958delC",
      "protein_notation": "p.L320fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Age not specified, MC subtype",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "MC",
          "evidence_sentence": "We detected 24 germline mutations in 22 ovarian cancer patients. Among the 24 germline HR-associated gene mutations, 12 (50%) were detected in HGSC patients, and almost all of them were either BRCA1 or BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant was not detailed in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation",
      "source_location": "Table 2, Row 9",
      "additional_notes": "This variant was identified in a patient with MC.",
      "key_quotes": [
        "BRCA2 mutation was identified in one patient each of CCC, EC, and MC."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Germline variants and clinical features.",
      "variants_extracted": 5
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 5,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}